Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Specker

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2008
CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosisBenjamin Wilde, Sebastian Dolff, Xin Cai, et al.
Clinical and Experimental Rheumatology|April 6, 2021
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?Rebecca Hasseli, Alexander Pfeil, Bimba F Hoyer, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Annals of the Rheumatic Diseases|May 15, 2020
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Joachim Listing, Jan Zernicke, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
Zeitschrift Fur Rheumatologie|October 20, 2022
[Rheumatology training positions in Germany]Alexander Pfeil, Martin Krusche, Fabian Proft, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
Zeitschrift Fur Rheumatologie|August 11, 2023
[Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST]Fabian Proft, , Diana Vossen, et al.
Zeitschrift Fur Rheumatologie|October 17, 2023
Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSSTFabian Proft, Diana Vossen, Xenofon Baraliakos, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2008
CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosisBenjamin Wilde, Sebastian Dolff, Xin Cai, et al.
Clinical and Experimental Rheumatology|April 6, 2021
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?Rebecca Hasseli, Alexander Pfeil, Bimba F Hoyer, et al.
Clinical and Experimental Rheumatology|July 15, 2020
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritisChristof Specker, Annette Alberding, Martin Aringer, et al.
Annals of the Rheumatic Diseases|May 15, 2020
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trialClaudia Kedor, Joachim Listing, Jan Zernicke, et al.
Zeitschrift Fur Rheumatologie|July 1, 2021
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]Rebecca Hasseli, Alexander Pfeil, Bimba Franziska Hoyer, et al.
RMD Open|September 4, 2020
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRDRebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, et al.
Zeitschrift Fur Rheumatologie|October 20, 2022
[Rheumatology training positions in Germany]Alexander Pfeil, Martin Krusche, Fabian Proft, et al.
RMD Open|January 22, 2021
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseasesRebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, et al.
Zeitschrift Fur Rheumatologie|August 11, 2023
[Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST]Fabian Proft, , Diana Vossen, et al.
Zeitschrift Fur Rheumatologie|October 17, 2023
Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSSTFabian Proft, Diana Vossen, Xenofon Baraliakos, et al.
Pageof 8